Wong Kin Sang – Country Manager, Lundbeck Malaysia
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Address: Menara Hap Seng, No. 1 & 3,10th Floor, Jalan P Ramlee, 50250 Kuala Lumpur ,Malaysia
Tel: 603-5121 5819
Web: http://www.lundbeck.com/global
We are a research-based company. We engage in research to find new drugs for treatment of CNS disorders, includ ing depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, epilepsy and insomnia.
These are serious disorders. They affect not only patients, but also their families and friends. Besides the stress of having a CNS disorder, patients are often exposed to prejudice because, in many sections of society, there is still far too little understanding of how adversely a CNS disorder affects an individual’s life.
We have taken upon ourselves the task of improving quality of life for persons with a psychiatric or neurological disorder, and we are working intensely to find and develop new and improved drugs. We believe that we can make a significant difference, and we are happy to do so in cooperation with others.
Depression, schizophrenia, Alzheimer’s, Parkinson’s and sleep disorders have their foundation in the central nervous system – our key focus areas. Here are some in depth information to help you better understand these diseases.
Our products
Cipralex® Antidepressant Ebixa® Anti-Alzheimer’s Azilect® Anti-Parkinson’s Serdolect® Schizophrenia Circadin® Insomnia Sabril® Epilepsy Xenazine® Huntington’s disease
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
You have worked in the pharmaceutical industry for many years starting with Novartis and you have spent the last eight years working for Lundbeck. What are the major changes that…
David Ho, managing director of Hovid, introduces the success story of his family-owned company, which started at a Chinese herbal tea manufacturer and became one of the biggest local generic…
Dr Goh Pik Pin, director of the Clinical Research Centre (CRC), and Dr Salina Abd Aziz, consultant psychiatrist and chairperson, MOH Medical Research Ethics Committee, and head, CRC Hospital Kuala…
Tunku Naquiyuddin and Tunku Mohamed Alauddin, respectively executive chairman and managing director of the Antah Healthcare Group highlight the importance of close business relationships between stakeholders in Malaysia and its…
Sea cucumbers – odd-looking marine animals with leathery skins and elongated bodies – can be found on ocean floors worldwide. Although more famous as a culinary delicacy in East and…
Datuk Seri Dr. Haji Dzulkefly bin Ahmad, Malaysia’s Minister of Health, sets out his vision and key priorities for healthcare in the country over the course of the new parliamentary…
Günther Beissel, CEO of the Malaysia International Trade and Exhibition Centre (MITEC), highlights the venue’s unique proposition within Malaysia’s business events industry and MITEC’s journey to become Southeast Asia’s leading…
Dr Hassan Yaakob of Healwell Pharmaceutical Co. Ltd., discusses the company’s rejuvenating and anti-ageing products, made from a polypeptide derived from sea cucumber. He also gives insights into the changing consumer…
Dr. Fadzilah Kamaludin, the director of the Institute for Medical Research (IMR) in Malaysia, highlights the important role of the IMR, as a public organization, to help the research in…
Ewe Kheng Huat, executive director of PhAMA, the Malaysian association for innovative companies, describes the current market environment for innovative medicines in Malaysia, from the difficulties to enter the Malaysian…
Fabio Sperandei has been the country head for Sandoz Malaysia for four years. Here, he explains the key success factors that led Sandoz to become the leading multinational generic company…
Dr Akhmal Yusof, CEO of CRM sheds light on the capacity for all stages of clinical research in Malaysia. He discusses the importance of human resources for the country’s research…
Smit Soni, Kalbe country manager for Malaysia and Singapore, explains the dynamics in the consumer healthcare market in Malaysia, and how Kalbe is ensuring that its products are being adapted…
See our Cookie Privacy Policy Here